Paradigm Biocapital Advisors LP 13D and 13G filings for Autolus Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:32 pm Sale | 2024-09-30 | 13G | Autolus Therapeutics plc AUTL | Paradigm Biocapital Advisors LP | 0 0.000% | -12,611,335 (Position Closed) | Filing |
| 2024-02-14 4:08 pm Purchase | 2023-12-31 | 13G | Autolus Therapeutics plc AUTL | Paradigm Biocapital Advisors LP | 12,611,335 7.200% | 2,512,751 (+24.88%) | Filing |
| 2023-07-10 5:00 pm Purchase | 2023-06-30 | 13G | Autolus Therapeutics plc AUTL | Paradigm Biocapital Advisors LP | 10,098,584 5.800% | 10,098,584 (New Position) | Filing |